Streetbeat News

Price Targets

RMD

Mizuho analyst Anthony Petrone maintains a 'Buy' rating on ResMed (NYSE:RMD) but lowers the price target from $180 to $160.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 7:06 pm

V

Mizuho analyst Dan Dolev has maintained a Neutral rating on Visa (NYSE:V) and raised the price target from $240 to $243.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 7:05 pm

MA

Mizuho analyst Dan Dolev has maintained a 'Buy' rating on Mastercard (NYSE:MA) but lowered the price target from $435 to $420.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 7:03 pm

WEX

Mizuho analyst Dan Dolev has maintained a 'Buy' rating on WEX (NYSE:WEX), but lowered the price target from $225 to $200.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 7:00 pm

VYNE

HC Wainwright & Co. analyst Joseph Pantginis maintains a 'Buy' rating on VYNE Therapeutics but has lowered the price target from $28 to $5.75.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:59 pm

ADP

Mizuho analyst Dan Dolev has maintained a 'Buy' rating on Automatic Data Processing (NASDAQ:ADP) but lowered the price target from $285 to $255.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:59 pm

WT

Oppenheimer analyst Chris Kotowski maintains an Outperform rating on WisdomTree (NYSE:WT) but has lowered the price target from $10 to $9.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:55 pm

ABBV

AbbVie Inc reported better-than-expected Q3 earnings and raised its profit outlook, leading to a 2.8% rise in its shares. Following the announcement, Barclays and Morgan Stanley increased their price targets on AbbVie.

Portfolio Pulse from Lisa Levin

October 30, 2023 | 6:55 pm

BKNG

Oppenheimer analyst Jed Kelly has reiterated an Outperform rating on Booking Holdings (NASDAQ:BKNG) and maintained a price target of $3700.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:53 pm

B

Oppenheimer analyst Christopher Glynn maintains an Outperform rating on Barnes Group (NYSE:B) but has lowered the price target from $48 to $30.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:50 pm